Neuronal expression of tumor necrosis factor alpha in the OVOUJI fme brain

NeuroImmunoModulation

Volumn 3, Issue 5, 1996, Pages 289-303

  Gahring, Lorise C ^a,c   Carlson, Noel G ^a,b,d   Kulmer, Rachel A ^c   Rogers, Scott W ^a,c,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Geriatrics Division   (United States)

^c Program in Human Molecular Biology and Genetics   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine; Immunohistochemistry; Single cell RT PCR; Tumor necrosis factor alpha

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN REGION; CELL CULTURE; CONTROLLED STUDY; GLIA CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALS; BRAIN; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MICE, INBRED DBA; NEURONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 12644251968     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000097283     Document Type: Article

References (49)

1. Hopkins SJ, Rothwell NJ: Cytokines and the nervous system I. Expression and recognition. Trends Neurosci 1995:18:83-88.
2. Faggioni R, Benigni F, Ghezzi P: Proinflam-matory cytokines as pathogenic mediators in the centra] nervous system: Brain-periphery connections. Neuroimmunomodulaiion 1995; 2:2-15.
3. Cheng B, Christakos S, Mattson MP: Tumor necrosis factor protects neurons against meta-bolic-cxcilotoxic insults and promote maintenance of calcium homeostasis. Neuron 1994: 12:139-153.
4. + accumulation. Proc Natl Acad Sci USA 1995:92:9328-9332.
5. Selmaj K, Raine CS: Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988:23:339-346.
6. Probert L, Akassoglou K, Pasparkis M, Konto-georgos G, Kollias G: Spontaneous inflammatory' demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor a. Proc Nall Acad Sci USA 1995:92:11294-11298.
7. Chao CC, Hu S: Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cultures. Dev Neurosci 1994:16: 172-179.
8. Selmaj K, Raine CS, Canella B, Brosnan CF: Identification of lymphotoxin and tumor necrosis factor-alpha in multiple sclerosis lesions. J Clin Invest 1991:87:949-954.
9. Raine CS: The Dale McFarlin Memorial Lecture: The immunology of the multiple sclerosis lesion. Ann Neurol 1994;36:S61-S72.
10. Cannella B, Raine CS: The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 1995:37:424-435.
11. Nuovo CJ, Gallen I, MaeConnell P, Braun A: In «iu dcicclion of polymerase chain reaction-amplified 111V-1 nucleic acids and iunior necrosis factor-alpha RNA ill the central nervous system. Am J Pathol 1994:144:659-666.
12. Will SG, Milliard I, Zhou JM, Nagasaki K, Patton II, Rusten R, Grillen DH, O'Connor M, Duhois-Daleii M: In i itro evidence for a dual role of tumor necrosis factor-alpha in human immunodeficiency liras type I encephalopathy. Ann Neurol 1995:37:381-391
13. Cchnn CL, Ileyes MP, WileyCA: Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J Clin Invest 1993:91:2769-2775.
14. Glinialter M, Rrugsbjerg P, Lorsgren M, Oleen P: Tumor necrosis factor-alpha (I NI -alpha) in cerebrospinal fluid from palientsiiith meningitis of different etiologies: I ligli levels of TNI u indicate bacterial meningitis. J Infect Dis 1993: 167:882-889.
15. Mogi M, Ilarada M, Riederer P, Narabaynshi II, Lujita K, Nagatsu I: I umor necrosis factor-alpha (TNF-alpha) increases in both the brain and m the cerebrospinal lluid from Parkinsonian patients. Neurosci Lett 1994:165:208-210.
16. Boka G, Inglade P, Wallach D, Javoy-Agid I, Agid V, Ilirsch EC: Immunocytochemical analysis of tumor necrosis factor and us receptors in Parkinson's disease. Neurosa Lett 1994: 172:151-154.
17. Meda I, Cassatella MA, Szendrei GI, Onosl O, Baron P, Viilalba M, Ferrari D, Rossi F: Acti-vation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 1995:374: 647-650.
18. Porta J, Carota V, Pizzolato GP, Wilde I, Widmer MC, Margairaz C, Grau OF: Imniu-nopathological changes in human cerebral malaria. Clin Neuropatliol 1993:12:142-146.
19. I'chelirigeriaii JL, Munge M, Le Saux F, Zalc H, Jacque C: Differential oligodendroglial expression of the tumor necrosis factor receptors in vivo and in vitro. J Ncuroclicm 1995:65:2377-2380.
20. Sommer N, Loschmann PA, Northoff GIL, Weller M, Steinbrccher A, Sleinbach JP, Lich-lenfels R, Meyermaiin R, Riethmuller A. Fontana A. Dicltgans J. Martin R: The antidcprcs-sant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nature Med 1995:1 244-248
21. Peterson PK, Hu S, Sheng WS, Kravitz FH, Molitor TW, Chatterjee D, Chao CC: Thalidomide inhibits tumor necrosis factor-alpha production by lipopolysaccharidc and lipoara-hinoniannaii-stiniulated human microglial cells. J Infect Dis 1995:172:1137-1140.
22. Rosenblum MG, Donalo MJ Tumor necrosis factor alpha: 3 multifaceted peptide hormone. Crii Rev Immunol 1989:9:21-44.
23. Beutler B: TNI. immunity and inflammatory disease: Lessons of the past decade. J Invest Med 1995,43:227-235
24. Juhler M, Neuvvclt LA: Theblood-brain barrier and the immune system: in Neuvvelt L\(ed): Implication of the Blood-Brain Barrier and Its Manipulations. New York. Plenum Press. 1989. pp 261-292.
25. Brosnan CF, Claudio L, Martiney JA: The blood-brain barrier during immune responses. Neuroscience 1992:4:19.3.
26. Ortas B, Camurcu S, Kava M: Influence of sex on the blood brain barrier permeability during bicueullinc-induced seizures, lilt J Neurosci 1992:65:131-139.
27. Broadwell RD. Banks WA: A cell biological pcrspectn e for the transcy tosis of pcpt ides and proteins through the mammalian blood-brain lluid barriers: in Pardrtdge B M (ed): The Blood-Rrain Barrier: Cellular and Molecular Biology. New York. Raven Press. 1993. pp 165.
28. Lee SC, Liu B, Dickson DB, Bronsan CL, Bronsan JB: Cytokine production by human fetal microglia and astrocytes Differential induction by lipopolysaccharidc and ILI-β. J Immunol 1993;150:2659-2667.
29. llredcr CD, Isujiniolo M, Terano Y, Scott DB, Saper CBV: Distribution and characterization of tumor necrosis lactor-u-like itnniunore-activity in the murine central nerv ous system. J Comp Neurol 1993:337:543-567.
30. Tchclingcrian JL. Quinoncro I, Booss J, Jacquc C: Localization ofTNFa and II.-In inimuno-reaetivities in striatal neurons after surgical iniury to the hippocampus. Neuron 1993:10: 213-224.
31. Tchclingcrian JL, Signais L, Jacquc C: INF alpha gene expression is induced in neurons after a hippocampal lesion. Neuroreport 1994: 5:585-588.
32. Batanabe M, Sakimura K, Takahasln Y, Rondo II: Oniogcnic changes in expression of neuronal-specific enolase (NSF) and its niRN.A in the Purkinje cells of the ral cerebellum: Imniu-nohistochemical and iti situ hybridization study Dex Brain Res 1990:53:89-96.
33. Rogers SB, Hughes T, Iiollmann M, Gassie G, Deneris F, Ileincniann S: The characterization and localization of the glutamate receptor subunit. GluRl. in the ral brain. J Neurosci 1991: 11:2713-2724.
34. Skeen GA, Tvvyman RF, Blnte I IS The diliy-dropyridme nitrendipine modulates N-methyl-β-aspartale receptor channel function in mammalian neurons. Mol Pharmacol 1994:44:443-450.
35. Chomczynski P, Saeehi N Single step method of RN A isolation by acid guanidtmum thiocva-nate-phenol-chloroform extraction. Anal Bio-chem 1987:162:156-159.
36. Gilliland G, Pcrrm S, Bunn HF: Competitive PCR for quantitation ofmRN'A: in Innis MA. Gelfand OH. Snisky JJ. JJlute IJ edsl: PCR Protocols: a guide to methods and applications. New York. Academic Press. 1990. p60.
37. Ciattt S, Bartlai T: Induction of tumor necrosis Dictor-ii mRNA in the brain after peripheral endotoxin treatment: Comparison with interleukin-1 and interleukin-6. Brain Res 1993: 624:291-294.
38. Minami M. Kuraishi B, Saloh M: Effects ol kainie acid on messenger RN\levels of ll.-lL II.-6. TNFu. and LIF m the rat brain, Btoehem Biophys Res Conumin 1991:176:593-598
39. Cauley K. Marks M. Guhring I.C. Rogers SAX Nicotinic receplor subunits u.3. i:4. and i2 and high-al'finily nicotine binding sites are expressed by PI9 embryonal cells. J Ncurobiol 1996:30:303-314.
40. Fberwine J, Aeh II, Miyashiro R, Can A, Nan S, Finnell R, Zettel M, Coleman P: Analysis of gene expression in single live neurons. Proc Natl Acad Seil'S-A 1992:89:3010-3014.
41. Litton M.I. Sander B. Murphy I O'Garra A. Abrams.IS Early expression of cytokines in lymph nodes after treatment in vivo with Staphylococcus enterotoxm B. J Immunol Methods 1994:175:47-58.
42. Rogers S33 Mandelzys A. Deneris L. Cooper L. Heiitemann S: The expression of nicolinie acetylcholine receptors by PC 12 cells treated With NGL. J Neurosci 1992.12:4611-4623
43. Gahring I.C. I'wyman RF. Greenlee JL. Rogers SNA: Autoantibodies to neuronal glutamate receptors m patients with paraneoplastic ncuro-degeneratixc syndrome enhance receptor activation. Mol Med 1995:1:245-253.
44. I'wyman RL. Gahrmg LC. Spciss J. Rogers SB: Glutamate receptor antibodies activate a subset of receptors and reveal ail agonist binding site. Neuron 1995:14:755-762.
45. Mirtella A. Pozzoli G. Preziosi P. Grossman B, Navarra P: Release of immunoreaettve interleukin-1-alpha from rat hypothalamic explains is increased by bacterial lipopolysaceharidc and high RCI concentrations. Neuroimmuno-modulation 1994:1:23-27.
46. Breder CD. Hazuka C. Ghayur T. Rlug C. Huginin M. A'asuda R. Tcng M. Sapcr C: Regional mduciion of lumor necrosis factor β expression in the mouse brain alter systemic lipopolysaccharidc administration. Proc Natl Acad Sci TSA 1994:91 11393-11397.
47. Chung I A, Bcnvcniste LN: lumor necrosis factor-» production by astrocytes. J Immunol 1990:144:2999-3007.
48. Chung IA. Norris JG. Bcnvcntstc EN Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and resistant rat strains, BJPMed 1991:173:801-811.
49. Miller LG. Galpcrn 33 R. Dunlap R. Dmarello A, Turner T. I Imerleukin-I augments gam-ma-anuno-butyrte acid\ receptor function in brain. Mol Pharmacol 1991:39:105-108.